Peter D. O'Hanley
Overview
Peter D. O'Hanley received an average of $567K in total compensation, including $260K in salary, at Sarepta Therapeutics from 2006 to 2008.
Source: SEC filing on April 14, 2009.
Related executives
We found 30 more executives who work or worked at Sarepta Therapeutics.
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
Ryan Brown
Sarepta Therapeutics
General Counsel
William Ciambrone
Sarepta Therapeutics
Executive Vice President, Technical Operations
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
David Howton
Sarepta Therapeutics
General Counsel
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
Sandesh Mahatme
Sarepta Therapeutics